Collegium Pharmaceutical, Inc. (COLL) Minute Stock Prediction

About:

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Employees:

234

Address:

Collegium Pharmaceutical, Inc. 100 Technology Center Drive Suite 300 Stoughton MA 02072 United States

Website:

Home

Phone:

781-713-3699